Pharmaceuticals, Biotechnology and Life Sciences
Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval Toro Hero Toro Neurovascular’s catheter technology,…
ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) — Following 10+ years of service to Cushing’s syndrome patients, Optime Care, a…
BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel…
SAN FRANCISCO and BOSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…
WOODCLIFF LAKE, N.J., Oct. 06, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of…
– Robust improvement demonstrated across diverse set of clinical measures – – Patient-reported outcomes support clinical meaningfulness of improvements in…
Châtillon, France, October 6, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program…
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide…